Mario Germano Giuliani
Overview
- Source of Wealth
- Pharmaceuticals
- Industry
- Healthcare
- Residence
- Monaco
- Education
- Catholic University of the Sacred Heart (Bachelor of Arts/Economics)
- Marital Status
- Married
Assets
- HBM Healthcare Investments AG550,306 shares @ --HBMN-CH
- Royalty Pharma21,600,000 shares @ --RPRX-US
Biography
Mario Germano Giuliani is a healthcare investor who owns an 8% stake in Royalty Pharma, the world's largest acquirer of pharmaceutical royalties.
Royalty Pharma went public in 2020 and has collected revenue slices of blockbuster drugs like Humira, Imbruvica, Lyrica and Xtandi.
Mario and his brother Giammaria also own stakes in Swiss investment company HBM Healthcare Investments and a number of biotech firms in the U.S.
The brothers share ownership of their family's pharmaceutical company, Giuliani, founded by their great-grandfather Germano in Milan, Italy in 1889.
They also own real estate investments in Europe and the U.S., including a planned commercial and residential project on a maritime platform in Monaco.
About
The family company's best-known product is Amaro Giuliani, a herbal digestive remedy invented by Germano, a chemist, when he bought a pharmacy in Milan in 1889.